Nicotinamide Mononucleotide

Especificaciones

1094-61-7Número CAS

214-136-5Número CE

[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphateNombre IUPAC

C11H15N2O8PFórmula química

334.22 g/molPeso molecular

1094-61-7; nicotinamide mononucleotide; Nicotinamide ribotide; 2KG6QX4W0V; Pyridinium, 3-(aminocarbonyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)-, inner salt; DTXSID50911152; [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate; Alpha9; ((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl hydrogen phosphate; 3-carbamoyl-1-((2R,3R,4S,5R)-5-((hydrogen phosphonatooxy)methyl)-3,4-dihydroxyoxolan-2-yl)-1$l^(5)-pyridin-1-ylium; 3-carbamoyl-1-[(2R,3R,4S,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1$l^{5}-pyridin-1-ylium; ELITEHEALTH; REUS NR; RefChem:854107; Mononucleotide, Nicotinamide; CHEBI:50383; DTXCID001511294; 214-136-5; 3-carboxy-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-((phosphonooxy)methyl)oxolan-2-yl)-1lambda5-pyridin-1-ylium; beta-Nicotinamide mononucleotide; beta-NMN; NMN zwitterion; NMN; nicotinamide nucleotide; nicotinamide ribonucleotide; beta-nicotinamide D-ribonucleotide; nicotinamide D-ribonucleotide; BETANMN; beta-Nicotinamide ribonucleotide; MFCD00038748; ((2R,3S,4R,5R)-5-(3-Carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen phosphate; 3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium; B-NICOTINAMIDE MONONUCLEOTIDE; Nicotinamide ribonucleoside 5'-phosphate; beta-nicotinamide ribose monophosphate; b-D-NMN; C11H15N2O8P; BETA-D-NMN; UNII-2KG6QX4W0V; reinvigorator; Fosribnicotinamide; EINECS 214-136-5; ss-NMN; Nicotine Impurity 9; Nicotinamidmononucleotid; fosribnicotinamide [INN]; -NM;NMN; bmse000260; -Nicotinamide mononucleotide; ?-Nicotinamidemononucleotide; Nicotinamide Mononucleotide?; NMN [MI]; |A-Nicotinamidemononucleotide; ?-Nicotinamide Mononucleotide; ss-Nicotinamide mononucleotide; fA-Nicotinamide Mononucleotide; SCHEMBL105618; |_-Nicotinamide Mononucleotide; CHEMBL610238; orb1302620; orb3141445; SCHEMBL19064261; CHEBI:16171; b-Nicotinamide ribose monophosphate; GLXC-21427; EX-A3534; HY-F0004; BDBM50366763; MSK157075; Nicotinamide mononucleotide [WHO-DD]; |A-Nicotinamide Mononucleotide (NMN); 3-(Aminocarbonyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridinium inner salt; AKOS015896881; CCG-267847; CS-4996; EBC-616152; NN45555; 3-carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide 5'-(dihydrogen phosphate) inner salt; MSK157075-1000W; 3-carbamoyl-1-[(2R,3R,4S,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1lambda5-pyridin-1-ylium; AC-35057; AS-59655; SY129470; N1123; T4721; C00455; H11919; F455506; Q21547155; beta-Nicotinamide mononucleotide Solution in Water, 1000ug/mL; beta-Nicotinamide Mononucleotide(Discontinued,See C4X-20199); 3-Carbamoyl-1-[5-O-(hydroxyphosphinato)-beta-D-ribofuranosyl]pyridin-1-ium; 3-carbamoyl-1-[5-O-(hydroxyphosphinato)-beta-D-ribofuranosyl]pyridinium; 3-(AMINOCARBONYL)-1-(5-O-PHOSPHONO-.BETA.-D-RIBOFURANOSYL)PYRIDINIUM INNER SALT; 3-(aminocarbonyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridinium, inner salt; ((2R,3S,4R,5R)-3,4-dihydroxy-5-(3-(hydroxy(imino)methyl)pyridin-1-ium-1-yl)tetrahydrofuran-2-yl)methyl hydrogen phosphate; ((2R,3S,4R,5R)-5-(3-carbamoylpyridinium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen phosphate; [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate; [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methylhydrogenphosphate; 3-carbamoyl-1-[(2R,3R,4S,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1??-pyridin-1-yliumSinónimos